NEWS
SSRP Institute
Aug 21, 2026

Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC

HEADLINE SCIENCE

[August 21, 2026] - JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the molecule into the body, causing a delayed allergy to red meat and dairy. Referring to a study conducted by the US Centers for Disease Control and Prevention (CDC), the report  points to a wide ranging presence of alpha-gal immunoglobulin E (IgE) antibodies as ranging from anywhere between 6% to 31%. Not everyone who carries the antibodies develops the allergy to red meat, the primary effect of the syndrome. In a study of 3,000 donor blood samples (2024-2025), the prevalence of the syndrome was as high as 24%. However, this number “far exceeded” the 2022 estimate of 45,000 people. The samples were derived from ten U.S. states, including the five with the highest prevalence – Arkansas, Kentucky, Missouri, Tennessee, and Virginia.

Read the Full Report

For further details, please refer to: https://jamanetwork.com/journals/jama/fullarticle/2852753

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Nov 2, 2026
Ep. 112 - Peptide Therapy Gets a Smarter Upgrade
Preview only
Dissecting Protocols – Episode 112

Peptide Therapy Gets a Smarter Upgrade

Dr. Seeds addresses the often-overlooked challenges of peptide purity, patient adherence, and administration. He also shares the journey behind the Redox Smart Pen, highlighting years of collaboration with scientists, physicians, and formulators to help raise the standard for peptide therapy and advance the future of cellular medicine.

Preview Only — Become a member for full access
SSRP Institute Oct 29, 2026
Dr. Seeds and Medivive Announce the Redox Smart Pen: A Novel Technology for Precise Peptide Administration
BREAKING NEWS WILLOUGHBY, Ohio [October 29, 2026] — Dr. Seeds and Medivive announce the launch of the Redox Smart Pen, an innovative pre-filled autoinjector peptide delivery system designed to improve precision and consistency in physician-directed peptide protocols. Importantly, the Redox Smart Pen was developed through a proprietary methodology focused on uniform potency, accuracy of administration, […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 26, 2026
Ep. 111 - Can BPC-157 & HBOT Prevent Amputation?
Preview only
Dissecting Protocols – Episode 111

Can BPC-157 & HBOT Prevent Amputation?

Dr. Seeds explores the potential and limitations of these investigational approaches, emphasizing the importance of blood flow, patient phenotyping, and cellular function in limb salvage. (Question Link)

Preview Only — Become a member for full access
PharmaNutra Oct 22, 2026
SSRP Institute Welcomes PharmaNutra as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [October 22, 2026] — The SSRP Institute announces that PharmaNutra has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process. Founded in Italy in 2003, PharmaNutra is a pharmaceutical and nutraceutical company focused on the research, development, and production of nutritional supplements and medical devices. […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Oct 19, 2026
Ep. 110 - Phenotyping is Essential to Cellular Medicine
Preview only
Rabbit Holes – Episode 110

The Macrophage Mystery: Decoding Aging

In Part 3 of our Anti-Aging Mini Mastermind, Dr. Seeds explores how aging alters PGE2/EP2 signaling, influencing macrophage metabolism, immune function, and inflammation, and examines potential therapeutic implications.
Articles referenced: (2026 Article) (2021 Article)

Preview Only — Become a member for full access
VIDEO
Cellular Medicine Mondays
Oct 12, 2026
Ep. 109 - Anti-Aging Mini Mastermind Part 2
Preview only
Journal Club – Episode 109

Anti-Aging Mini Mastermind Part 2

In Part 2 of our Anti-Aging Mini Mastermind series, Dr. Seeds explores how PGE2 signaling and cellular metabolism influence inflammation, cognitive function, and aging, connecting foundational research to emerging discoveries in immunometabolism.  (2026 Article) (2021 Article)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
William Seeds, MD Oct 8, 2026
EP2, Tissue-Resident Macrophages, and a New Mechanism of Organ Aging
Revisiting a Journal Club Article, “Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging.” Science. 2026  Why This Paper Matters Most of the senescence conversation over the past decade has centered on a familiar cast: senescent fibroblasts, endothelial cells, adipocytes, and the drugs designed to clear them. This paper, which I discuss in […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Oct 5, 2026
Ep. 108 - Dr. Seeds’ Office Hours
Preview only
Dr. Seeds’ Office Hours – Episode 108

Dr. Seeds’ Office Hours – Episode 108

Questions Answered:
1. ARA-290 for Post Op 47yo Male [0:53]
2. Cold Therapy and the Wim Hof Method [17:06]

Preview Only — Become a member for full access
Healthgevity Oct 2, 2026
Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research
BREAKING NEWS INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity. The formula reflects the cellular medicine approach advanced by William Seeds, MD, and […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Sep 28, 2026
Ep. 107 - Anti-Ageing Mini Mastermind Part 1
Preview only
Journal Club – Episode 107

Mini Anti-Aging Mastermind Part 1: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging

Part 1 of a special Mini Anti-Aging Mastermind inspired by the recent Science article exploring how impaired clearance of senescent neutrophils may contribute to age-related organ decline. Dr. Seeds begins breaking down the cellular mechanisms behind the research and what they reveal about the biology of aging. (Article Link)

Preview Only — Become a member for full access

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.